Deccan Health Care
13.85
+0.30(+2.21%)
Market Cap₹34.24 Cr
PE Ratio23.77
Company Performance:
1D+2.21%
1M-14.82%
6M-34.79%
1Y-49.73%
5Y-53.83%
View Company Insightsright
More news about Deccan Health Care
14Aug 25
Deccan Health Care Limited Approves Q1 FY2026 Financial Results
Deccan Health Care Limited's Board of Directors approved the unaudited financial results for Q1 FY2026 ending June 30, 2025. The board meeting was held on August 14, 2025, via video conferencing. Both standalone and consolidated results were approved after review by the Audit Committee. Director Mohak Gupta is authorized to sign the results. The company will upload the results on its website and submit them to BSE Limited, complying with SEBI regulations.
Deccan Health Care
13.85
+0.30
(+2.21%)
1 Year Returns:-49.73%
Industry Peers
Dr. Lal Path Labs
1,415.60
(-0.38%)
Metropolis Healthcare
1,898.70
(-0.42%)
Krsnaa Diagnostics
712.25
(-1.74%)
Suraksha Diagnostic
266.70
(-0.21%)
3B BlackBio DX
1,523.25
(+4.65%)
Sastasundar Ventures
329.00
(-0.29%)